EMCDDA Home
  • EN
Search

Stay informed

Follow us on Twitter

Follow us on 

Subscribe to RSS news feed RSS feed

Media support

To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations unit:

Kathy Robertson
Head of sector
Media relations and marketing
Tel: (351) 211 21 02 00/32
Fax: (351) 211 21 03 80

Maria José Louro
Media relations assistant
Tel: (351) 211 21 02 00/40
Fax: (351) 211 21 03 80

2011 EMCDDA scientific paper award — 14 November, Lisbon

EMCDDA celebrates scientific writing with new award

Lisbon, 11.11.2011 (News release No 6/2011)

Download news release and abstracts

News release (Word)
Download this attachment in DOC format
News release (PDF)
Download this attachment in PDF format
Abstracts (Word)
Download this attachment in DOC format
Abstracts (PDF)
Download this attachment in PDF format

Five scientific papers judged to enhance understanding of the European drugs problem will be acclaimed on Monday evening in Lisbon in a new award ceremony hosted by the EU drugs agency (EMCDDA) and its Scientific Committee (1).

The prize, to be awarded annually in Lisbon, celebrates scientific writing in this area of key concern to EU citizens. The inaugural event, on 14 November, will be held in the margins of the EMCDDA Scientific Committee meeting. It takes place on the eve of the launch of the Annual report 2011: the state of the drugs problem in Europe.

Over 50 eligible entries, from 13 countries (12 EU + Norway), were received in this first year from a variety of disciplines, nationalities and languages. The entries were analysed by a jury consisting of members of the EMCDDA Scientific Committee and scientific staff on the criteria of: scientific significance; EU policy relevance; originality and creativity; and clarity and quality of writing. The articles were published in 2010 in peer-reviewed scientific journals, with the primary author based in an EU Member State or Norway.

Award winners
From left to right: Wolfgang Götz, EMCDDA Director, Maria Moreira, Drug-related research information officer (EMCDDA), Professor Dr. philos, Edle Ravndal (Norway), Norah Palmateer, MSc, BScH (United Kingdom), Marina Davoli, Chair EMCDDA Scientific Committee, Bernd Schulte, BPH, cand. PhD (Germany), Gregorio Barrio Anta, MD, PhD (Spain), Gerhard Bühringer, Vice-Chair EMCDDA Scientific Committee.

The five winners (three male, two female) will receive a non-monetary prize for the following papers:

  • ‘Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance’, primary author, Bernd Schulte, BPH, cand. PhD (Germany);
  • ‘Estimating the prevalence of drug injection using a multiplier method based on a register of new HIV diagnoses’, primary author, Gregorio Barrio Anta, MD, PhD (Spain);
  • ‘Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition’, primary author, Fiona Measham, PhD (United Kingdom);
  • ‘Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews’, primary author, Norah Palmateer, MSc, BScH (United Kingdom); and
  • ‘Mortality among drug users after discharge from inpatient treatment: an 8-year prospective study’, primary author, Professor Dr. philos, Edle Ravndal (Norway).

The importance of scientific publishing has been underlined regularly by the Scientific Committee and the  upcoming prize reflects this. Abstracts of the winning papers will be available online in English, along with translations in German, French and Portuguese in an effort to share findings in non-English speaking countries.

Commenting on the initiative, EMCDDA Director Wolfgang Götz said: ‘Our Scientific Committee provides a strong voice for scientific standards and I welcome its initiative for lauding papers of merit in our field of drugs and drug addiction. Ensuring that the findings of European research are made available to the policy and practice community is an important issue. I hope this award will become a useful channel for disseminating these results’.

Notes

(1) For more on the Scientific Committee see www.emcdda.europa.eu/about/sc
 

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 18 November 2011